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TCF11 is a ubiquitous transcription factor of the CNC-bZIP family. The activity of this vital protein is strictly regulated and we have
previously published that the two major translated protein forms show a clearly different transactivation ability in transient transfections.
Only the full-length form is active in a variety of mammalian cells [J. Biol. Chem. 276 (2001) 17641]. Here we further investigate the
complex regulation of TCF11, studying the cellular localisation of some of the different protein isoforms. The full-length form is located both
in the cytoplasm and the nucleus, while the internally initiated shorter protein form is restricted to nuclear localisation. A nuclear export
signal (NES) localised in the N-terminus of TCF11 is responsible for the active nuclear export of the protein. This export is highly sensitive to
leptomycin B (LMB) and is largely blocked by mutating three of the leucine residues in the signal region. These results indicate that export
occurs through the Crm1-mediated pathway. Due to alternative splicing within the tcf11 gene, different isoforms of the longer protein form
are produced. Some of these isoforms, one identical to Nrf1, lack the NES and are thereby restricted to nuclear localisation.D 2003 Published by Elsevier Science B.V.Keywords: TCF11; Nuclear export; Transcription factor; CNC-bZIP; Nrf1; p45 NF-E21. Introduction
TCF11 is a human basic leucine zipper (bZIP) tran-
scription factor [2]. It is grouped together with p45 NF-
E2, Nrf2, Nrf3, Bach1 and Bach2 [3–6] in the CNC-bZIP
subfamily due to sequence similarities among the proteins.
Among these proteins, p45 NF-E2 and Nrf2 are best
characterised. p45 NF-E2 is shown to be involved in the
control of globin gene expression [7], and platelet formation
and function [8,9]. For Nrf2, several studies have revealed
that it is important in antioxidant response regulating gene
expression by binding to ARE elements in the promoter
region of some detoxifying enzymes [10]. Although TCF11
has also been implicated in regulation of the antioxidant
response [11,12], the complete biological function of TCF11
is not fully understood. However, the importance of tcf110167-4889/03/$ - see front matter D 2003 Published by Elsevier Science B.V.
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2, Ireland.has been shown by two different inactivations of the gene in
mouse [13,14], showing that TCF11 is vital during develop-
ment. We have recently shown that the two major translation
products, a longer form of 772 amino acids and a shorter
form of 447 amino acids, have different abilities to activate
a reporter in a transient transfection assay, where only the
longer form is active [1]. In addition, production of the
shorter protein interferes with transcriptional activation by
full-length TCF11. Here we further examine the differences
between naturally occurring isoforms of TCF11, showing
how alternative splicing and translation initiation alter
cellular localisation. In addition to the two major translation
products, we have studied two other isoforms lacking 11 or
41 amino acid residues in the N-terminal acid rich domain.
The former protein isoform is also known as Nrf1 [35].
The physical separation of nuclear and cytoplasmic
functions is an important mechanism for regulation of
cellular processes in eukaryotic cells. So far, all known
transport between the nucleus and the cytoplasm occurs
through the nuclear pore complex (reviewed in Ref. [15]).
The import pathway is quite well understood and it is
known that nuclear import requires energy, physiological
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ble transport machinery (reviewed in Ref. [16]). However,
less is known about how molecules are exported out of the
nucleus. The best-characterised export pathway makes use
of a leucine rich nuclear export signal (NES) in the trans-
located protein. The NES might be bound by the export
receptor Crm1 (also named exportin 1) in the presence of
Ran-GTP in the nucleus and the trimeric complex is then
exported to the cytoplasm [17,18]. However, the absence
of a leucine-rich NES or the inability to block Crm1-
mediated export does not rule out the possibility that a
protein is actively exported [19,20].
During the last few years, short leucine-rich NESs have
been identified within a variety of proteins like HIV-1
regulatory protein Rev [21,22], protein kinase A inhibitor
(PKI) [23], mitogen-activated protein kinase kinase
(MAPKK, also known as MEK) [24], cyclin B [25], phos-
pholipase C-y1 [26], Stat1 [27], the atypical protein kinase
C E (E PKC) [28] and InBa [29]. The export ability of the
majority of these proteins is influenced by the addition of
leptomycin B (LMB) [25–31]. It has been shown that LMB
binds specifically to the export receptor Crm1, thus prevent-
ing the formation of stable NES–Crm1 complexes [32,33].
This makes LMB a general inhibitor of a multitude of NES-
mediated nuclear pathways [34].
In this study, we have examined the subcellular local-
isation of different native protein forms of TCF11 and how
the ability to be actively exported from the nucleus to the
cytoplasm varies between the different isoforms. Only the
full-length form of TCF11 is actively exported from the
nucleus to the cytoplasm. Mutation and deletion studies
locate the NES in a leucine-rich area within the N-terminal
transactivating domain of TCF11. This signal is not present
in the naturally occurring TCF11 isoforms previously
referred to as Nrf1 [35] (D242–271) and long variant
TCF11 [1] (D171–181;242–271), due to alternative splic-
ing within the gene. The export signal is also absent in the
internally initiated translation product (short TCF11 protein
[1]; identical to LCRF1 [36]), and all three protein isoforms
show strict nuclear localisation. The functional implications
of such a control mechanism are discussed.2. Materials and methods
2.1. Expression constructs
The different constructs expressing TCF11 long and
short forms (pcA20), short form only (pcA52), long form
only (pcA20IntMut), the D171–181;242–271 variant of
TCF11 (pcA56), the different mutant variants (12–125,
D173–315 and 412–315), p45 NF-E2 and the TCF11/
p45 NF-E2 chimeric proteins (NATDB, NASerTDB,
TANDB and TASerNDB) are all previously described
[1]. The long form variant of TCF11 (pcA56 [1]) is
missing two amino acid stretches in the N-terminal acid-rich domain. Two additional mutant constructs were pro-
duced that miss each of these stretches individually,
TCF11D171–181 and D242–271 (the numbers refer to
the amino acid residues deleted). To produce the
TCF11D171–181 construct the sequence 5Vto PshAI from
pcA56 was ligated to the PshAI/EcoRV (restriction sites at
bp 1173 and 3550 in the tcf11 sequence, Accession No
X77366 [2]) sequence of pcA20. In the TCF11D242–271
construct, the PshAI/EcoRV sequence from pcA56 was
combined with the 5Vto PshAI sequence of pcA20. The
longer NES–GFP construct expressing NES(1–326)GFP
(the numbers refer to the amino acid residues from TCF11
included in the construct) was made by cloning the 5Vend
to NcoI (bp 1567) sequence of pcA20 into the pECFP-N1
expression vector (Clontech). The shorter NES–GFP con-
struct expressing NES(1–11,126–326)GFP was made by
cloning the 5Vend to NcoI sequence of the deletion D12–
125 into the pECFP-N1 expression vector. The N-terminal
FLAG tagged constructs were made by cloning the XmnI/
EcoRV sequence from pcA20 (long form, bp 624–3550)
or the BglII/EcoRV sequence (short form, bp 1537–3550)
into the pFLAG-CMV2 expression vector (Kodak Scien-
tific Imaging System). The expression construct pcA20-
NESMut producing the full-length TCF11 with a mutated
NES sequence (TCF11 NES mutated) was made by
mutating three leucine residues (L253, L257 and L260)
to alanine residues using the QuickChange Site-Directed
Mutagenesis strategy (Stratagene).
2.2. Cell culture and transient transfections
COS-1 cells were cultured and transiently transfected as
previously described [1]. Briefly, the cells were cultured in
DMEM (1g/l glucose, Life Technologies) supplemented
with 10% foetal calf serum, 2 mM L-glutamine and pen-
icillin–streptomycin (50 U/ml) at 37 jC in 5% CO2. At
50–80% confluence, the cells were transfected by using
FuGENE 6, following the supplier’s instructions (Boeh-
ringer Mannheim). A total of 1.0 Ag of expression vector
per 3.5-cm dish was used together with 2–3 Al of trans-
fection reagent. The cells were harvested 24 h post trans-
fection. When required, the cells were incubated with either
LMB (3 ng/ml) or actinomycin D (ActD, 10 Ag/ml) for 3 h.
2.3. Immunocytochemistry
COS-1 cells were transfected with the different expres-
sion plasmids and cultured for 24 h. The cells were fixed
with 4% paraformaldehyde (PFA) for 7 min at room temper-
ature and blocked in 1% BSA in phosphate-buffered saline.
The fixed cells were incubated with anti-TCF11 antibody
[37] overnight at 4 jC and then with fluorescence isothio-
cyanate-conjugated (FITC) anti-rabbit IgG (DAKO) for 1 h
at room temperature. After washing, the cells were mounted
in fluorescent mounting medium (MOWIOL) and examined
by fluorescence microscopy.
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3.1. The long and short forms of TCF11 have different
cellular localisation
Localisation of many transcription factors has been
shown to be an important level for regulating protein
function. Both import to and export from the nucleus can
be regulated (reviewed in Ref. [16]). We show here that in
cells transfected with a construct expressing the full-length
coding region of wild-type TCF11 (Fig. 1A, long), the
protein is detected in both the nucleus and the cytoplasm
(Fig. 1B, left panel). A similar protein localisation pattern is
observed in primary cells prepared from the trunk region of
mouse embryos at 11.5 days post coitum (dpc) overexpress-
ing TCF11 (data not shown). This is in contrast to what has
been observed with other CNC-bZIP transcription factors. It
has previously been shown that Bach2 is primarily localised
in the cytoplasm in QT-6 cells [38]. Nrf2 is predominantly
in the nucleus when transiently transfected in 293T cells.
However, KeapI has the ability to retain Nrf2 in the
cytoplasm, when the two proteins are co-expressed [39].Fig. 1. The short and long forms of TCF11 protein show different subcellular lo
(long), the internally initiated shorter protein (short) and a mutated version of th
translation initiation is abolished. The different structural motifs within the protein
rich domain, the CNC domain (CNC, highly conserved among the family of the
(dimerisation domain) (bZIP) are shown. The two different translation initiation s
cluster (MMMM), are also marked. In the mutated protein variant, the four inte
leucine residues (LLLL). (B) Full-length TCF11 is localised in both the nucleus
panel), while treatment with LMB restricts the localisation to the nucleus (central
long mutated form also shows both cytoplasmic and nuclear localisation (left pane
The TCF11 shorter form shows a protein localisation that is limited to the nucleus
with a polyclonal antibody against the C-terminus of TCF11 [37], followed by in
antibodies with the dilutions used visualise only the transiently expressed TCF11
transfection, the cells were incubated with LMB (3 ng/ml) or ActD (10 Ag/ml) for 3
using FuGENE as the transfection method.p45 NF-E2 is strictly localised to the nucleus (Fig. 2B, left
panel). TCF11 is assumed to harbour a NLS in the basic
region of the protein since similar regions in other bZIP
factors have been shown to be NLS signals [38,40,41]. To
investigate if the observed cytoplasmic localisation of the
protein was due to poor or incomplete nuclear import or
rapid nuclear export, the transiently transfected cells were
treated with either LMB, which is a specific inhibitor of
Crm1-dependent nuclear export [17,32,42] or the transcrip-
tion inhibitor ActD, which can inhibit nuclear import of
proteins involved in RNA transport [43,44]. When the cells
were incubated in the presence of LMB, TCF11 protein was
efficiently restricted to the nucleus (Fig. 1B, central panel)
while ActD did not have any influence on the protein
localisation (Fig. 1B, right panel). This indicates that the
cytoplasmic localisation is due to active export of the
protein from the nucleus.
From the wild-type sequence of TCF11, both short and
long protein products are expressed through the use of
alternative start codons. We have recently shown that these
two naturally occurring protein forms have different trans-
activating ability [1]. While the longer protein positivelycalisation patterns. (A) Schematic representation of the full-length TCF11
e longer protein (long mutated) expressed from a sequence where internal
are indicated. The N-terminal transactivating domain (acid-rich), the serine-
CNC–bZIP factors) and the basic (DNA binding domain) leucine zipper
tart sites, which are the initial methionine (M) and the internal methionine
rnal methionine residues (M318, M321, M323 and M326) are changed to
and in the cytoplasm in untreated transiently transfected COS-1 cells (left
panel). No effect is observed upon treatment with ActD (right panel). The
l) that is restricted to nuclear localisation upon LMB treatment (right panel).
(left panel). The cells were fixed in PFA 24 h after transfection, and stained
cubation with a secondary FITC-conjugated antibody. This combination of
and not the endogenously expressed protein. Where indicated, 24 h after
h, followed by fixation in PFA. The cells were transfected with 1.0 Ag DNA
Fig. 2. Nuclear export of TCF11 is conferred by the N-terminal part of the protein. (A) A schematic representation of TCF11 long form, p45 NF-E2 and the
different chimeric TCF11/NF-E2 proteins [1]. The different shaded boxes indicate the same domains as given in Fig. 1A. In the chimeric constructs, the
numbers indicate the amino acid residues in the protein of origin. Numbers above the drawing indicate domains from TCF11, whereas numbers below the
drawing indicate a domain from p45 NF-E2 (also dot filled). The names of the different constructs are given as p45 NF-E2 or TCF11 (N or T) Activating
domain fused with p45 NF-E2 or TCF11 (N or T) DNA Binding domain. When the serine-rich region is incorporated, Ser is added to the name of the chimeric
protein [1]. (B) The different chimeric proteins of TCF11/p45 NF-E2 show different localisation in transiently transfected COS-1 cells (left panel). Incubation
with LMB only interfered with the cellular localisation of TANDB and TASerNDB (right panel). The cells were transfected, fixed and stained as described in
Fig. 1B. The primary antibody recognises both TCF11 and p45 NF-E2 proteins, which have similar C-termini [37].
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fact interferes with the activity of the full-length version. To
investigate if there were any differences in the localisation
pattern between the two protein forms, we examined the
protein localisation when either a mutated construct that can
only produce the longer protein (through prevention of
internal translation initiation), or an incomplete clone that
can only produce the shorter protein, were transiently trans-
fected into COS-1 cells. The longer mutated form (Fig. 1A,
long mutated) showed the same localisation pattern as
TCF11 wild type being normally located to both the nucleus
and cytoplasm (Fig. 1B, left panel) but restricted to nucleus
when incubated with LMB (Fig. 1B, right panel). In con-trast, the internally initiated shorter protein form (Fig. 1A,
short) showed a strictly nuclear localisation that was not
affected by the presence of LMB (Fig. 1B, both panels).
These results demonstrate that TCF11 long form is actively
exported from the nucleus through an LMB-sensitive path-
way. The potential for such export must be located to the N-
terminal part of the protein.
3.2. The nuclear export potential of TCF11 can be
transferred to other proteins
Our results showed that the N-terminal region of TCF11
is essential for the protein’s export from the nucleus to the
Table 1
Identified leucine-rich NESs in various proteins and several NES-like
sequences in the N-terminal region of TCF11 (the region spanning the
amino acid residues from 1 to 318)
Amino acid
Rev 73–83 L Q L – P P L E R – – L T L
PKIa 36–46 E L A L K L A G – – L D I
MAPKK 32–44 A L Q K K L E E – – L E L D E
Cyclin B 141–152 D L C Q A F S D – – V I L A
PLC-y 164–177 E L K D F L K E – – L N I Q V
Stat1 305–314 T F S L F Q Q L I Q
EPKC 247–256 S L – – G L Q D – – F D L L
InBa 45–55 M V K E L Q E – – I R L E
TCF11 2–13 L S L K K Y L T E G – L L
12–24 L L Q F T I L – – – L S L I G V
36–44 L – P P L R E – – I I L
83–90 L L S Q V R A – – L
174–185 L I D I L W R Q D I D L
251–260 L S L E E C L R L – – L
292–301 L Q N N L L S P – L L
C. Husberg et al. / Biochimica et Biophysica Acta 1640 (2003) 143–151 147cytoplasm. In order to address whether this region is
sufficient to confer nuclear export to a protein normally
restricted to the nucleus, a chimeric protein with the N-
terminal part of TCF11 fused to the CNC-bZIP domain of
p45 NF-E2 was used (Fig. 2A, TANDB) [1]. As a control,
we also examined the localisation pattern of the reciprocal
construct containing the N-terminal part of p45 NF-E2 and
the CNC-bZIP domain of TCF11 (Fig. 2A, NATDB). Since
phosphorylation is well known to interfere with the intra-
cellular localisation of many proteins (reviewed in Refs.
[16,19]) chimeric fusions including the serine-rich stretch
from TCF11 were also examined (Fig. 2A, TASerNDB and
NASerTDB). This region is observed to be a very potent
phosphorylation target in vitro (data not shown) and we
have previously shown that it is required for TCF11 to be
fully active [1]. We observed that the chimeric proteins
containing the N-terminal part of TCF11, TASerNDB and
TANDB were located both in the cytoplasm and nucleus
(Fig. 2B, left panel). The observed cytoplasmic localisation
was efficiently inhibited upon treatment with LMB (Fig. 2B,
right panel). Thus, the N-terminal region of TCF11 can
impart cytoplasmic localisation to a heterologous nuclear
protein. In addition, chimeric proteins with distinct regions
of N-terminal TCF11 fused to GFP were prepared. Tran-
siently transfected constructs expressing these proteins in
COS-1 cells gave a mainly cytoplasmic localisation (data
not shown), again indicating that the N-terminal part of
TCF11 confers nuclear export ability to the fusion proteins.
Only nuclear localisation was observed for p45 wild type
and the mutant proteins with the N-terminal part of p45,
NASerTDB and NATDB (Fig. 2B, left panel). Since no
additional effect on the localisation patterns was observed
when the serine-rich domain from TCF11 was included in
the different mutant proteins, we conclude that phosphor-
ylation in this region is not critical for the ability to export
TCF11 from the nucleus.
3.3. One specific leucine-rich sequence in TCF11 is
responsible for the protein’s nuclear export
The examination of the N-terminal protein sequence of
TCF11 revealed seven leucine-rich regions, which all might
be export signals due to their similarity with other known
NESs (Table 1; Fig. 3). To determine more closely which
regions are important for the nuclear export, plasmids that
express mutant proteins were constructed. In FLAG N-term
LF, only the most N-terminal leucine-rich region was
deleted (Fig. 3). To ensure that the addition of a FLAG-
tag did not interfere with the export abilities of the protein, a
construct expressing the shorter form of TCF11 fused to
FLAG was made (Fig. 3, FLAG N-term SF). In D12–315
(the numbers refer to the amino acid residues deleted [1]),
all putative NESs except the most N-terminal were deleted.
In each of D12–125 and D173–315, three leucine-rich
sequences were deleted (Fig. 3), specifically the second to
fourth (D12–125) and the fifth to seventh (D173–315)putative export signals. Among these mutant proteins, only
FLAG N-term LF and D12–125 were located in both the
nucleus and cytoplasm (Fig. 3, left panel). The localisation
of these proteins was efficiently restricted to the nucleus
when the cells were treated with LMB (Fig. 3, right panel).
The other mutant proteins (FLAG N-term SF, D12–315 and
D173–315) showed nuclear localisation, which was not
affected by addition of LMB (Fig. 3, both panels). These
results indicate that the export potential of TCF11 is
localised among the three most C-terminal leucine-rich
regions.
When tcf11 was identified, several isoforms were isolated
[2]. One of the isoforms encodes a protein variant (TCF11
long variant [1]) missing two of the putative export signals
due to alternative splicing within the gene (Fig. 3, D171–
181;242–271). The localisation pattern of this protein
variant showed that the omission of two regions of 11 and
30 amino acid residues, respectively, was enough to com-
pletely abolish nuclear export (Fig. 3, left panel). We then
produced and examined the localisation of two mutant
proteins each containing one of the deletions (Fig. 3,
D171–181 and D242–271). We observed that D171–181
showed the same localisation as TCF11 wild type (Fig. 3,
both panels). In contrast, the deletion of amino acid residues
242–271 was enough to completely abolish cytoplasmic
localisation (Fig. 3, left panel). Within this sequence, there
are several leucine residues that might be important for
nuclear export and we chose to further examine residues
L253, L257 and L260. When these were mutated to alanine
residues (Fig. 3, NES mutated), the cellular localisation
pattern was altered. The majority of export of this altered
protein from the nucleus to the cytoplasm was blocked (Fig.
3, left panel). From these results, we conclude that the NES
of TCF11 is located between the amino acid residues 242
and 271, and that the leucine residues in position 253, 257
and 260 are important in the translocation of the protein.
C. Husberg et al. / Biochimica et Biophysica Acta 1640 (2003) 143–151148
C. Husberg et al. / Biochimica et Biophysica Acta 1640 (2003) 143–151 1494. Discussion
Many transcriptional regulators that enter the nucleus
require a mechanism for turning off or modulating their
activity under the appropriate conditions. For example, the
essential tumour suppressors pRb (reviewed in Ref. [45])
and p53 (reviewed in Ref. [46]) are changed from an
inactive to an active form by phosphorylation. Another
mechanism to control a nuclear protein is to keep it under
rapid degradation, which is the situation with c-Myc,
another critical component for the control of normal cell
growth (reviewed in Ref. [47]). In addition, the entrance to
and accumulation of a protein in the nucleus can be under
strict regulation. This is exemplified by NF-nB, which is
retained in the cytoplasm when it is bound to the partner InB
(reviewed in Ref. [48]). Regarding the CNC-bZIP tran-
scription factors, different mechanisms are used to control
their activity and access to target genes. The nuclear local-
isation of p45 NF-E2 is not known to be directed by any
specific mechanism; however, the protein is only expressed
in haematopoietic tissues and is thereby under strict control
at this level. In the case of p45 NF-E2, it has been suggested
that its activity is regulated by phosphorylation, a modifi-
cation that might be important in erythroid differentiation
[49,50]. The widely expressed Nrf2 is under a similar
control mechanism to NF-nB. The activity of Nrf2 is
normally repressed by binding to the cytoplasmic inhibitor
Keap1, but this repression is released upon oxidative stress
when the protein can be translocated to the nucleus [39].
From the study presented here, it is clear that TCF11 is
regulated through yet another mechanism. The full-length
form of the protein is actively exported from the nucleus
through an LMB-sensitive pathway. Three leucine residues
(L253, L257 and L260) are important in this export and we
therefore assume that the pathway involves the export
receptor Crm1.
We previously showed that full-length TCF11 and the
long-variant D171–181;242–271 show the same ability to
transactivate through a single NF-E2 site in transient trans-
fections [1]. In addition, the mutant protein D242–271,
which is identical to an isoform of TCF11, Nrf1, has also
been shown to transactivate through the NF-E2 site [5]. We
have confirmed this result in our transfection assay (data notFig. 3. Mapping of the NES in TCF11. (A) A schematic representation of TCF11 l
protein are indicated as in Fig. 1A. In the enlarged representation of the N-terminal
The numbers indicate the amino acid residues within the possible NES signals. Th
FLAG) lacks the amino acid residues 1–11. The shorter FLAG tagged protein star
the acid-rich domain is deleted, and D12–315 has a deletion covering most of the N
in the N-terminal acidic rich domain. In D171–181;242–271, a natural occurrin
terminal acid-rich domain were deleted. Each of these signals are deleted individu
leucine residues (L253, L257 and L260) are mutated to alanine residues. (B) The d
transfected COS-1 cells. It is only the N-terminal FLAG long form, the D12–125 a
cytoplasm and the nucleus (left panel), a localisation pattern that is restricted to nu
protein shows a weak cytoplasmic localisation in addition to the nuclear localisat
with LMB (right panel). The rest of the mutant proteins (N-terminal FLAG shor
strictly nuclear localisation (left and right panel). All the cells were treated as deshown). The transfection assays therefore indicate that
translocation from the nucleus to the cytoplasm does not
interfere with the activity of the different TCF11 isoforms.
These three protein variants show clearly different cellular
localisation patterns since only full-length TCF11 is
exported to the cytoplasm. However, in vivo, with endog-
enous levels of protein in a balanced situation, small
modulations in the level of available protein may have
much larger effects on gene expression decisions. On the
other hand, nuclear export may rather play a role in another
aspect of TCF11 function, for example to allow interaction
with and perhaps co-translocation of other cytoplasmic
proteins. The fact that two naturally occurring isoforms of
TCF11 lack the export signal due to alternative splicing
within the gene and are therefore restricted to nuclear
localisation indicates that translocation represents an impor-
tant modulatable level of regulation.
Much of the research so far concerning TCF11 and
Nrf1 has focused on the analysis of DNA binding through
various response elements and dimerisation with different
partners. These studies have not exposed significant differ-
ences between the two isoforms. However, it cannot be
excluded that TCF11 and Nrf1 have differential activities
and properties under certain physiological conditions
within the cells. Our results indicate that one of the
reasons why differential splicing occurs in exon four
might be to alter the subcellular localisation of the protein.
Alternative splicing has been confirmed to change the
cellular localisation of other proteins like Bach1 and
dystrophin Dp71 [51,52]. One might speculate that during
certain cellular stages, it is important to export TCF11 out
of the nucleus. This might be to interact with a specific
partner in the cytoplasm or just to shut down transcription
of target genes in the nucleus. Similarly, the capture of
Nrf1 in the nucleus might be important during specific
stages where an elevated level of target genes is required.
In addition, nuclear localisation might prolong the life-
time of a TCF11 active form and thereby extend the
transcription of target genes. It is clear that additional
experiments are required to understand the complete
physiological consequence of the differential localisation
of the isoforms, but our results indicate that subcellular
localisation represents one additional level for regulatingong form and the different deleted versions. The structural motifs within the
part of the protein, several leucine-rich domains are indicated (black boxes).
e longer protein N-terminally tagged with eight amino acids (DTKDDDDK,
ts at amino acid residue 316. In D12–125, most of the protein N-terminal to
-terminus In D173–315, amino acid residues 173–315 have been removed
g variant of TCF11 [2], two different possible NES signals within the N-
ally in the D171–181 and the D242–271 constructs. In NES mutated, three
ifferent mutant proteins of TCF11 show different localisation in transiently
nd the D171–181 proteins that show a clear protein localisation in both the
clear localisation upon treatment with LMB (right panel). The NES mutated
ion (left panel). This localisation is restricted to the nucleus upon treatment
t form, D12–315, D173–315, D171–181:242–271 and D242–271) show
scribed in Fig. 1B.
C. Husberg et al. / Biochimica et Biophysica Acta 1640 (2003) 143–151150the activity of TCF11. Preliminary experiments in primary
cells prepared from 11.5 dpc mouse embryos show that
the level of accumulation of TCF11 in the cytoplasm
varies widely in different cell types, further evidence that
this mechanism is used to differentially regulate TCF11
(data not shown). We hypothesise from our observations
here, combined with our previous study [1], that alter-
native translation initiation is a level of regulation used to
control the activity of TCF11 [1] while alternative splicing
might be a means of controlling the localisation of the
active form of TCF11.References
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